Joseph A. Trapani

Active 1985–2025

138
Papers
25,577
Citations
91
h-index
136
i10-index

Citations

Citations per year for Joseph A. Trapani1979: 6 citations1987: 1 citations1988: 1 citations1989: 6 citations1990: 6 citations1991: 9 citations1992: 7 citations1993: 3 citations1994: 4 citations1995: 14 citations1996: 40 citations1997: 123 citations1998: 137 citations1999: 145 citations2000: 153 citations2001: 242 citations2002: 225 citations2003: 248 citations2004: 255 citations2005: 248 citations2006: 223 citations2007: 252 citations2008: 161 citations2009: 253 citations2010: 284 citations2011: 175 citations2012: 157 citations2013: 157 citations2014: 137 citations2015: 224 citations2016: 148 citations2017: 178 citations2018: 206 citations2019: 623 citations2020: 718 citations2021: 808 citations2022: 955 citations2023: 670 citations2024: 1,019 citations2025: 555 citations2026: 18 citations1980–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,056 citing papers, 28.2% of this breakdownChina: 1,605 citing papers, 14.8% of this breakdownAustralia: 669 citing papers, 6.2% of this breakdownGermany: 609 citing papers, 5.6% of this breakdownUnited Kingdom: 543 citing papers, 5% of this breakdownCanada: 387 citing papers, 3.6% of this breakdownFrance: 378 citing papers, 3.5% of this breakdownItaly: 370 citing papers, 3.4% of this breakdownJapan: 318 citing papers, 2.9% of this breakdownNetherlands: 235 citing papers, 2.2% of this breakdownSwitzerland: 217 citing papers, 2% of this breakdownSpain: 213 citing papers, 1.9% of this breakdown
0%28.2%Other 20.7%

Fields

  • Medicine41.5%
  • Immunology and Microbiology26.9%
  • Biochemistry, Genetics and Molecular Biology25.7%
  • Engineering1.5%
  • Neuroscience1.1%
  • Nursing1.1%
  • Other2.2%

Topics

  • Immune Cell Function and Interaction9.8%
  • CAR-T cell therapy research7.3%
  • Immunotherapy and Immune Responses5.6%
  • Cancer Immunotherapy and Biomarkers4.9%
  • T-cell and B-cell Immunology4.2%
  • Cell death mechanisms and regulation2.9%
  • Other65.3%

Coauthors

All papers

Open in search
  1. Perforin and granzymes: function, dysfunction and human pathology

    Authors: , , - Nature reviews. Immunology 2015 cited by 1,288

  2. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2017 cited by 969

  3. Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion

    Authors: , , , , , , , , , , , , , , , , , - Cancer Research 2020 cited by 419

  4. Tumor immune evasion arises through loss of TNF sensitivity

    Authors: , , , , , , , , , , , , , , , , , - Science Immunology 2018 cited by 393

  5. Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2021 cited by 320

  6. Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 357

  7. Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Immunology 2020 cited by 215

  8. Functional significance of the perforin/granzyme cell death pathway

    Authors: , - Nature reviews. Immunology 2002 cited by 1,247

  9. Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian P. Wicks, Joseph A. Trapani, Ariel Munitz, Melissa J. Davis, Wei Shi, Paul J. Neeson, Gabrielle T. Belz - Nature Immunology 2021 cited by 175

  10. ESCRT-mediated membrane repair protects tumor-derived cells against T cell attack

    Authors: , , , , , , , , , , , , - Science 2022 cited by 131

  11. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claudia U. Duerr, Joseph A. Trapani, Emanuela Marcenaro, Tilmann Kallinich, Victor M. Corman, Florian Kurth, Leif Erik Sander, Christian Drosten, Sascha Treskatsch, Pawel Durek, Andrey Kruglov, Andreas Radbruch, Mir‐Farzin Mashreghi, Andreas Diefenbach - Nature 2021 cited by 280

  12. T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2023 cited by 97

  13. Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , - Molecular Therapy 2013 cited by 433

  14. Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2017 cited by 321

  15. Perforin-mediated target-cell death and immune homeostasis

    Authors: , , - Nature reviews. Immunology 2006 cited by 590

  16. Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science Advances 2022 cited by 94

  17. CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells

    Authors: , , , , , , , , , - Cancer Immunology Research 2015 cited by 148

  18. Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies

    Authors: , , , , , , , , , - The Journal of Immunology 2020 cited by 91

  19. Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 59

  20. Therapeutic strategies to remodel immunologically cold tumors

    Authors: , , , , - Clinical & Translational Immunology 2020 cited by 80

  21. Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time

    Authors: , , , , , , , - The Journal of Experimental Medicine 2015 cited by 254

  22. Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack

    Authors: , , , , , , , , , , , , - Blood 2013 cited by 251

  23. SUGAR-seq enables simultaneous detection of glycans, epitopes, and the transcriptome in single cells

    Authors: , , , , , , , , , , , , , , - Science Advances 2021 cited by 84

  24. Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 44